missing translation for 'onlineSavingsMsg'
Learn More
Learn More
STEMCELL Technologies SU5416
Click to view available options
Quantity:
10 mg
50 mg
Unit Size:
10mg
50mg
Description
- SU5416 is a tyrosine kinase inhibitor best known as an ATP-competitive inhibitor of the kinase insert domain (KDR/VEGFR2/FLK1)
- In addition to inhibiting KDR (IC50 = 1 μM), SU5416 also inhibits PDGFR (IC50 = 20 μM), KIT (IC50 = 30 nM), RET (IC50 = 170 nM), FLT-3 (IC50 = 160 nM), ABL (IC50 = 11 μM), and ALK (IC50 = 1.2 μM)
- SU5416 does not inhibit EGFR or FGFR tyrosine kinases (IC50 > 100 μM; Fong et al.; Litz; Mologni et al.)
- Prevents angiogenesis, thereby inhibiting tumor growth, catalysis and vascularization for a variety of cancers (Litz; Fong et al.)
- Inhibits RET-mediated transformation of NIH-3T3 mouse fibroblasts and Ba/F3 mouse pro-B cells (Mologni et al.)
- Causes pulmonary hypertension in SuHx rat model of pulmonary arterial hypertension, when combined with hypoxia (de Raaf et al.; Mizuno et al.)
- Inhibits TGFβ1 activation and delays wound healing in rats (Haroon et al.)
Specifications
Specifications
| CAS | 204005-46-9 |
| Synonym | NSC 696819; Semaxinib; Sugen 5416; VEGFR 2 Kinase Inhibitor |
| Quantity | 50 mg |
| Molecular Formula | C15H14N2O |
| Purity | ≥98% |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction